Compare $ALLR vs $TCRX | Chartloom

Compare

$ALLR vs $TCRX

Allarity Therapeutics Inc · TScan Therapeutics Inc

ALLR

Allarity Therapeutics Inc

TCRX

TScan Therapeutics Inc

Compare $ALLR vs $TCRX

Comparing Allarity Therapeutics Inc and TScan Therapeutics Inc

ALLRAllarity Therapeutics Inc

TCRXTScan Therapeutics Inc

ALLRAllarity Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-13.2%

52W performance

-41.8%

FCF yield

-87.5%

TCRXTScan Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.85x

Rev growth (TTM)

2.2%

YTD performance

-76.7%

52W performance

-88.0%

FCF yield

-761.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALLR

TCRX

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

TCRX

TScan Therapeutics Inc

Market Cap

ALLR$16M

TCRX$16M

Enterprise Value

ALLR$21M

TCRX$-52M

Price

ALLR$0.99

TCRX$0.24

P/E Ratio

ALLRN/A

TCRXN/A

P/S Ratio

ALLR45.65x

TCRX2.19x

EV/Sales

ALLR61.03x

TCRX-7.29x

EV/EBITDA

ALLR0.00x

TCRX0.00x

P/B Ratio

ALLR4.68x

TCRX0.31x

P/FCF Ratio

ALLRN/A

TCRXN/A

EV/FCF

ALLR-1.53x

TCRX0.44x

PEG Ratio

ALLRN/A

TCRXN/A

Forward P/E (NTM)

ALLRN/A

TCRXN/A

Forward P/S (NTM)

ALLRN/A

TCRX8.85x

Revenue (TTM)

ALLR$345K

TCRX$7M

Revenue Growth (YoY)

ALLRN/A

TCRX2.2%

Forward Rev Growth

ALLR0.0%

TCRX42.6%

Gross Margin (TTM)

ALLR0.0%

TCRX0.0%

Operating Margin (TTM)

ALLR0.0%

TCRX0.0%

EBITDA Margin (TTM)

ALLR-771.9%

TCRX-1626.5%

Net Margin (TTM)

ALLR-3575.1%

TCRX-1655.4%

FCF Margin (TTM)

ALLR-3994.8%

TCRX-1665.6%

Net Income (TTM)

ALLR$-12M

TCRX$-118M

FCF (TTM)

ALLR$-14M

TCRX$-118M

EPS (TTM)

ALLR-$0.78

TCRX-$0.91

ROE (TTM)

ALLR-15277.0%

TCRX-10872.0%

ROA (TTM)

ALLR-4650.0%

TCRX-5447.0%

ROIC (TTM)

ALLR-6256.0%

TCRX-8356.0%

Cash

ALLR$17M

TCRX$100M

Debt

ALLR$22M

TCRX$33M

Net Cash/Debt

ALLR$-5M

TCRX$67M

Current Ratio (TTM)

ALLR1.11x

TCRX3.37x

Quick Ratio (TTM)

ALLR0.99x

TCRX3.23x

Debt/Equity (TTM)

ALLR6.30x

TCRX0.47x

Debt/Assets (TTM)

ALLR0.0%

TCRX0.0%

Interest Coverage (TTM)

ALLRN/A

TCRXN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

TCRX0.00x

Beta

ALLR0.60

TCRX1.19

52W Performance

ALLR-41.8%

TCRX-88.0%

YTD Performance

ALLR-13.2%

TCRX-76.7%

% from 52W High

ALLR-46.2%

TCRX-90.7%

% from 52W Low

ALLR28.6%

TCRX6.1%

Asset Turnover (TTM)

ALLR0.00x

TCRX0.03x

FCF Yield (TTM)

ALLR-87.5%

TCRX-761.5%

Earnings Yield (TTM)

ALLR-78.3%

TCRX-756.8%

Dividend Yield (TTM)

ALLRN/A

TCRXN/A

Rule of 40

ALLR-3,994.8

TCRX-1,663.4

EV/GP/RG

ALLRN/A

TCRXN/A

Ticker research

View ALLR research View TCRX research

Metric	ALLR Allarity Therapeutics Inc	TCRX TScan Therapeutics Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$21M	$-52M
Price	$0.99	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	2.19x
EV/Sales	61.03x	-7.29x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.68x	0.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	0.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	8.85x
Revenue & Growth
Revenue (TTM)	$345K	$7M
Revenue Growth (YoY)	N/A	2.2%
Forward Rev Growth	0.0%	42.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	-1626.5%
Net Margin (TTM)	-3575.1%	-1655.4%
FCF Margin (TTM)	-3994.8%	-1665.6%
Net Income (TTM)	$-12M	$-118M
FCF (TTM)	$-14M	$-118M
EPS (TTM)	-$0.78	-$0.91
ROE (TTM)	-15277.0%	-10872.0%
ROA (TTM)	-4650.0%	-5447.0%
ROIC (TTM)	-6256.0%	-8356.0%
Financial Health
Cash	$17M	$100M
Debt	$22M	$33M
Net Cash/Debt	$-5M	$67M
Current Ratio (TTM)	1.11x	3.37x
Quick Ratio (TTM)	0.99x	3.23x
Debt/Equity (TTM)	6.30x	0.47x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.19
52W Performance	-41.8%	-88.0%
YTD Performance	-13.2%	-76.7%
% from 52W High	-46.2%	-90.7%
% from 52W Low	28.6%	6.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.03x
FCF Yield (TTM)	-87.5%	-761.5%
Earnings Yield (TTM)	-78.3%	-756.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	-1,663.4
EV/GP/RG	N/A	N/A
Ticker research	View ALLR research	View TCRX research

Valuation

P/S Ratio

TCRX

2.19x

ALLR

45.65x

EV/FCF

ALLR

-1.53x

TCRX

0.44x

Growth & revenue

Revenue Growth TTM

TCRX

2.2%

Forward Revenue Growth

TCRX

42.6%

ALLR

0.0%

Profitability & performance

Gross Margin

ALLR

0.0%

TCRX

0.0%

ROE

TCRX

-10872.0%

ALLR

-15277.0%

FCF Yield %

ALLR

-87.5%

TCRX

-761.5%

52-Week Performance

ALLR

-41.8%

TCRX

-88.0%

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

TCRX

TScan Therapeutics Inc

Market Cap

ALLR$16M

TCRX$16M

Enterprise Value

ALLR$21M

TCRX$-52M

Price

ALLR$0.99

TCRX$0.24

P/E Ratio

ALLRN/A

TCRXN/A

P/S Ratio

ALLR45.65x

TCRX2.19x

EV/Sales

ALLR61.03x

TCRX-7.29x

EV/EBITDA

ALLR0.00x

TCRX0.00x

P/B Ratio

ALLR4.68x

TCRX0.31x

P/FCF Ratio

ALLRN/A

TCRXN/A

EV/FCF

ALLR-1.53x

TCRX0.44x

PEG Ratio

ALLRN/A

TCRXN/A

Forward P/E (NTM)

ALLRN/A

TCRXN/A

Forward P/S (NTM)

ALLRN/A

TCRX8.85x

Revenue (TTM)

ALLR$345K

TCRX$7M

Revenue Growth (YoY)

ALLRN/A

TCRX2.2%

Forward Rev Growth

ALLR0.0%

TCRX42.6%

Gross Margin (TTM)

ALLR0.0%

TCRX0.0%

Operating Margin (TTM)

ALLR0.0%

TCRX0.0%

EBITDA Margin (TTM)

ALLR-771.9%

TCRX-1626.5%

Net Margin (TTM)

ALLR-3575.1%

TCRX-1655.4%

FCF Margin (TTM)

ALLR-3994.8%

TCRX-1665.6%

Net Income (TTM)

ALLR$-12M

TCRX$-118M

FCF (TTM)

ALLR$-14M

TCRX$-118M

EPS (TTM)

ALLR-$0.78

TCRX-$0.91

ROE (TTM)

ALLR-15277.0%

TCRX-10872.0%

ROA (TTM)

ALLR-4650.0%

TCRX-5447.0%

ROIC (TTM)

ALLR-6256.0%

TCRX-8356.0%

Cash

ALLR$17M

TCRX$100M

Debt

ALLR$22M

TCRX$33M

Net Cash/Debt

ALLR$-5M

TCRX$67M

Current Ratio (TTM)

ALLR1.11x

TCRX3.37x

Quick Ratio (TTM)

ALLR0.99x

TCRX3.23x

Debt/Equity (TTM)

ALLR6.30x

TCRX0.47x

Debt/Assets (TTM)

ALLR0.0%

TCRX0.0%

Interest Coverage (TTM)

ALLRN/A

TCRXN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

TCRX0.00x

Beta

ALLR0.60

TCRX1.19

52W Performance

ALLR-41.8%

TCRX-88.0%

YTD Performance

ALLR-13.2%

TCRX-76.7%

% from 52W High

ALLR-46.2%

TCRX-90.7%

% from 52W Low

ALLR28.6%

TCRX6.1%

Asset Turnover (TTM)

ALLR0.00x

TCRX0.03x

FCF Yield (TTM)

ALLR-87.5%

TCRX-761.5%

Earnings Yield (TTM)

ALLR-78.3%

TCRX-756.8%

Dividend Yield (TTM)

ALLRN/A

TCRXN/A

Rule of 40

ALLR-3,994.8

TCRX-1,663.4

EV/GP/RG

ALLRN/A

TCRXN/A

Ticker research

View ALLR research View TCRX research

Metric	ALLR Allarity Therapeutics Inc	TCRX TScan Therapeutics Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$21M	$-52M
Price	$0.99	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	2.19x
EV/Sales	61.03x	-7.29x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.68x	0.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	0.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	8.85x
Revenue & Growth
Revenue (TTM)	$345K	$7M
Revenue Growth (YoY)	N/A	2.2%
Forward Rev Growth	0.0%	42.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	-1626.5%
Net Margin (TTM)	-3575.1%	-1655.4%
FCF Margin (TTM)	-3994.8%	-1665.6%
Net Income (TTM)	$-12M	$-118M
FCF (TTM)	$-14M	$-118M
EPS (TTM)	-$0.78	-$0.91
ROE (TTM)	-15277.0%	-10872.0%
ROA (TTM)	-4650.0%	-5447.0%
ROIC (TTM)	-6256.0%	-8356.0%
Financial Health
Cash	$17M	$100M
Debt	$22M	$33M
Net Cash/Debt	$-5M	$67M
Current Ratio (TTM)	1.11x	3.37x
Quick Ratio (TTM)	0.99x	3.23x
Debt/Equity (TTM)	6.30x	0.47x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.19
52W Performance	-41.8%	-88.0%
YTD Performance	-13.2%	-76.7%
% from 52W High	-46.2%	-90.7%
% from 52W Low	28.6%	6.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.03x
FCF Yield (TTM)	-87.5%	-761.5%
Earnings Yield (TTM)	-78.3%	-756.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	-1,663.4
EV/GP/RG	N/A	N/A
Ticker research	View ALLR research	View TCRX research